(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 97.0%, 250mg

(S)-2-Amino-2-(3,4-dimethoxyphenyl)ethanol, 97%, 250mg

2-Pentene (cis- and trans- mixture), 95.0%, 100mg

6-Chloro-n-(prop-2-yn-1-yl)pyridine-3-carboxamide, 95%, 250mg

N-((2S,3R,4R,5S,6R)-2-(Benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide, 95.0%, 1g

4-Nitrobenzyl 2-(((tert-butyldimethylsilyl)oxy)methyl)-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate, 98%, 250mg

tert-Butyl 6,6-difluoro-2-azaspiro[3.3]heptane-2-carboxylate, 95.0%, 5g

2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 95.0%, 100mg

2,5,8,11-TETRAOXATETRADEC-13-YNE, 95.0%, 25g

2-Me-D-Trp-OH, 95.0%, 5g

(2-Aminobenzyl) carbamic acid tert-butyl ester, 95.0%, 1g

Polietilenglicol 8000, 500 g

(2-((tert-Butoxycarbonyl)amino)-7-fluorobenzo[d]thiazol-4-yl)boronic acid, 97%, 250mg